Simplex Trading
UTHR icon

Simplex Trading’s United Therapeutics UTHR Stock Holding History

Simplex Trading’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.2M Buy
+29,000
New +$14.4M 0.01% 482
2025
Q4 		– Sell
-27,300
Closed -$11.4M – 10163
2025
Q3 		$11.4M Buy
27,300
+20,100
+279% +$6.76M 0.01% 883
2025
Q2 		$2.07M Buy
7,200
+5,600
+350% +$1.67M ﹤0.01% 2072
2025
Q1 		$493K Buy
1,600
+100
+7% +$34.3K ﹤0.01% 3423
2024
Q4 		$529K Sell
1,500
-5,900
-80% -$2.17M ﹤0.01% 3481
2024
Q3 		$2.65M Sell
7,400
-18,700
-72% -$6.32M ﹤0.01% 2035
2024
Q2 		$8.31M Sell
26,100
-20,700
-44% -$5.48M 0.01% 1135
2024
Q1 		$10.8M Buy
46,800
+36,800
+368% +$8.3M 0.01% 1082
2023
Q4 		$2.2M Buy
10,000
+9,400
+1,567% +$2.17M ﹤0.01% 2279
2023
Q3 		$135K Sell
600
-1,400
-70% -$322K ﹤0.01% 4789
2023
Q2 		$441K Sell
2,000
-5,400
-73% -$1.2M ﹤0.01% 3444
2023
Q1 		$1.66M Buy
7,400
+4,300
+139% +$1.06M ﹤0.01% 2102
2022
Q4 		$862K Sell
3,100
-11,700
-79% -$2.95M ﹤0.01% 2609
2022
Q3 		$3.1M Buy
14,800
+12,400
+517% +$2.77M ﹤0.01% 1587
2022
Q2 		$565K Sell
2,400
-20,000
-89% -$4.07M ﹤0.01% 3294
2022
Q1 		$4.02M Buy
22,400
+22,000
+5,500% +$4.19M ﹤0.01% 1436
2021
Q4 		$86K Sell
400
-2,500
-86% -$491K ﹤0.01% 6486
2021
Q3 		$535K Hold
2,900
– – ﹤0.01% 3999
2021
Q2 		$520K Buy
+2,900
New +$552K ﹤0.01% 4109
2021
Q1 		– Sell
-68
Closed -$1.03M – 10120
2020
Q4 		$1.03M Buy
+68
New +$8.92K ﹤0.01% 2526
2020
Q3 		– Sell
-14
Closed -$169K – 8572
2020
Q2 		$169K Sell
14
-43
-75% -$4.84K ﹤0.01% 4187
2020
Q1 		$540K Sell
57
-120
-68% -$11.4K ﹤0.01% 2508
2019
Q4 		$1.56M Buy
177
+67
+61% +$5.9K ﹤0.01% 1701
2019
Q3 		$877K Sell
110
-81
-42% -$6.52K ﹤0.01% 2061
2019
Q2 		$1.49M Sell
191
-166
-46% -$15.5K ﹤0.01% 1548
2019
Q1 		$4.19M Buy
357
+243
+213% +$28.3K 0.01% 805
2018
Q4 		$1.24M Sell
114
-247
-68% -$28.6K ﹤0.01% 1460
2018
Q3 		$4.62M Buy
361
+113
+46% +$14K 0.01% 669
2018
Q2 		$2.81M Buy
248
+231
+1,359% +$25.4K 0.01% 897
2018
Q1 		$5K Sell
17
-65
-79% -$8.26K ﹤0.01% 4684
2017
Q4 		$8K Sell
82
-128
-61% -$16.3K ﹤0.01% 4123
2017
Q3 		$65K Sell
210
-171
-45% -$21.8K ﹤0.01% 2052
2017
Q2 		$111K Buy
381
+344
+930% +$42.9K ﹤0.01% 1664
2017
Q1 		$97K Sell
37
-56
-60% -$8.48K ﹤0.01% 1783
2016
Q4 		$24K Sell
93
-8
-8% -$1.02K ﹤0.01% 2871
2016
Q3 		$39K Sell
101
-1
-1% -$120 ﹤0.01% 2331
2016
Q2 		$49K Buy
102
+17
+20% +$1.9K ﹤0.01% 2081
2016
Q1 		$30K Buy
85
+58
+215% +$7.34K ﹤0.01% 2441
2015
Q4 		$44K Sell
27
-116
-81% -$16.9K ﹤0.01% 2026
2015
Q3 		$196K Buy
143
+117
+450% +$18.8K 0.01% 927
2015
Q2 		$23K Buy
26
+1
+4% +$180 ﹤0.01% 2345
2015
Q1 		$6K Sell
25
-69
-73% -$10.5K ﹤0.01% 3391
2014
Q4 		$5K Buy
+94
New +$12.1K ﹤0.01% 3126

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Simplex Trading's UTHR Position: Q4 2025 in Review

Simplex Trading sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 171 shares — an estimated $71K sold.

Simplex Trading first reported a position in UTHR in Q1 2015 and held it in 19 quarters. The position peaked at $1.83M in Q4 2017. 837 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • Simplex Trading reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 171 United Therapeutics shares in Q4 2025, an estimated $71K.
  • Simplex Trading first reported a position in United Therapeutics in Q1 2015 and held it in 19 quarters.
  • Simplex Trading's United Therapeutics position peaked at $1.83M in Q4 2017.
  • 837 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.